CLEC9A and neoplasm: NK cell-derived XCL1 has been strongly implicated in the direct recruitment and activation of Clec9a+XCR1+ cDC1s into solid tumors, with cDC1s being essential for tumor antigen cross-presentation in tumor-draining lymph nodes [17].